Vulvovaginal human papillomavirus infections

Clinical implications and management

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The past 2 decades have witnessed an alarming increase in the incidence of human papillomavirus infections. Clinically evident cases represent only a small portion of the infected population, because millions of people have subclinical or latent infection. Human papillomavirus infection is recognized as a precursor to malignancy. Thus it is important to treat clinically evident infection. Treatment is complicated by the ability of the virus to establish latent infection and the lack of an effective antiviral agent. At present treatment is limited to the destruction of obvious and intraepithelial lesions.

Original languageEnglish (US)
Pages (from-to)1183-1188
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume165
Issue number4 II SUPPL.
StatePublished - 1991

Fingerprint

Papillomavirus Infections
Infection
Antiviral Agents
Viruses
Incidence
Population
Neoplasms

Keywords

  • α-interferon
  • condyloma acuminata
  • human papillomavirus infection
  • laser therapy

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Vulvovaginal human papillomavirus infections : Clinical implications and management. / Hatch, Kenneth D.

In: American Journal of Obstetrics and Gynecology, Vol. 165, No. 4 II SUPPL., 1991, p. 1183-1188.

Research output: Contribution to journalArticle

@article{eb1f719c465b4bf190dd4ef0e050de54,
title = "Vulvovaginal human papillomavirus infections: Clinical implications and management",
abstract = "The past 2 decades have witnessed an alarming increase in the incidence of human papillomavirus infections. Clinically evident cases represent only a small portion of the infected population, because millions of people have subclinical or latent infection. Human papillomavirus infection is recognized as a precursor to malignancy. Thus it is important to treat clinically evident infection. Treatment is complicated by the ability of the virus to establish latent infection and the lack of an effective antiviral agent. At present treatment is limited to the destruction of obvious and intraepithelial lesions.",
keywords = "α-interferon, condyloma acuminata, human papillomavirus infection, laser therapy",
author = "Hatch, {Kenneth D}",
year = "1991",
language = "English (US)",
volume = "165",
pages = "1183--1188",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4 II SUPPL.",

}

TY - JOUR

T1 - Vulvovaginal human papillomavirus infections

T2 - Clinical implications and management

AU - Hatch, Kenneth D

PY - 1991

Y1 - 1991

N2 - The past 2 decades have witnessed an alarming increase in the incidence of human papillomavirus infections. Clinically evident cases represent only a small portion of the infected population, because millions of people have subclinical or latent infection. Human papillomavirus infection is recognized as a precursor to malignancy. Thus it is important to treat clinically evident infection. Treatment is complicated by the ability of the virus to establish latent infection and the lack of an effective antiviral agent. At present treatment is limited to the destruction of obvious and intraepithelial lesions.

AB - The past 2 decades have witnessed an alarming increase in the incidence of human papillomavirus infections. Clinically evident cases represent only a small portion of the infected population, because millions of people have subclinical or latent infection. Human papillomavirus infection is recognized as a precursor to malignancy. Thus it is important to treat clinically evident infection. Treatment is complicated by the ability of the virus to establish latent infection and the lack of an effective antiviral agent. At present treatment is limited to the destruction of obvious and intraepithelial lesions.

KW - α-interferon

KW - condyloma acuminata

KW - human papillomavirus infection

KW - laser therapy

UR - http://www.scopus.com/inward/record.url?scp=0025946075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025946075&partnerID=8YFLogxK

M3 - Article

VL - 165

SP - 1183

EP - 1188

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4 II SUPPL.

ER -